Aptabio Therapeutics (XKRX:293780) Shares Buyback Ratio % : -10.90 (As of May. 24, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Aptabio Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Aptabio Therapeutics's current shares buyback ratio was -10.90%.

Aptabio Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Aptabio Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptabio Therapeutics Shares Buyback Ratio % Chart

Aptabio Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-1.96

-0.03

-0.46

-10.90

Aptabio Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-10.90	-	-

Aptabio Therapeutics Shares Buyback Ratio % Calculation

Aptabio Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(22.299	-	24.730)	/	22.299
	=	-10.90%

Aptabio Therapeutics's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2024 )	-	Shares Outstanding (EOP) (A: Mar. 2025 ))	/	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	(24.730	-	24.730)	/	24.730
	=	0.00%

Aptabio Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Aptabio Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptabio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » Shares Buyback Ratio %

Traded in Other Exchanges

N/A

Address

13, Heungdeok 1-ro, Giheung-gu, Tower 504, Gyeonggi-do, Yongin-Si, KOR, 16954

Website

http://www.aptabio.com

Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.

Aptabio Therapeutics Headlines

No Headlines